Veterinary Oncology Market, By Animal Type (Companion Animal (Equine, Canine, and Feline) and Livestock Animal), By Therapy Type (Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy), By Mode of Administration (Oral and Intravenous), By
Veterinary Oncology Market, By Animal Type (Companion Animal (Equine, Canine, and Feline) and Livestock Animal), By Therapy Type (Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy), By Mode of Administration (Oral and Intravenous), By Application (Canine Lymphoma, Osteosarcoma (OSA), Mast Cell Cancer, Melanoma, and Others), By Distribution Channel (Hospital Pharmacies, Government Agencies, and Retail Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
The veterinary oncology market is experiencing significant growth due to rising animal healthcare expenditure and increasing pet ownership. Growing human-animal bonds and rising awareness about cancer in companion animals are propelling demand for advanced diagnostic methods and therapeutic procedures for veterinary oncology. Moreover, increasing incidence of cancers such as lymphoma, mammary tumor, oral melanoma, and mast cell tumors in dogs and cats is driving the need for effective treatment options and early detection. Growing number of veterinary oncologists and oncology specialists along with ongoing research for developing innovative drug formulations are further supporting market expansion on a global level. However, high costs associated with cancer therapies and diagnostic procedures remain a major challenge.
Market Dynamics:
The global veterinary oncology market growth is driven by rising incidence of cancer in companion animals, increase in pet insurance purchases, growing animal health expenditure, and technological advancements. According to statistics, over 50% of dogs over the age of 10 will develop cancer and lymphoma is the most common blood cancer in dogs. Rapid urbanization accompanied with rising nuclear families and increasing loneliness levels have boosted pet adoption rates globally. This has led to pet owners becoming more aware regarding the health of their pets and willing to spend more on premium treatments. Various organizations are financially supporting clinical trials and research activities related to veterinary oncology which is playing a significant role in market growth. However, high costs associated with oncology medications, diagnostic tests, surgeries, and lack of awareness in developing nations are anticipated to hamper the market expansion during the forecast period. Ongoing initiatives to spread awareness regarding cancer in pets through social media campaigns and conferences are expected to bring numerous lucrative opportunities for key players in the market.
Key Features of the Study:
This report provides an in-depth analysis of the global veterinary oncology market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary oncology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, One Health, and Regeneus Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary oncology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market
Detailed Segmentation-
By Animal Type:
Companion Animal
Equine
Canine
Feline
Livestock Animal
By Therapy Type:
Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy
By Mode of Administration:
Oral
Intravenous
By Application:
Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Others
By Distribution Channel:
Hospital Pharmacies
Government Agencies
Retail Pharmacies
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Zoetis Inc.
Elanco
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
VetDC
Morphogenesis, Inc.
Karyopharm Therapeutics, Inc.
Regeneus Ltd.
AdvaVet, Inc.
Rhizen Pharmaceutical SA.
PetCure Oncology
Varian Medical Systems
Accuray Incorporated
One Health
Regeneus Ltd.
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Animal Type
Market Snapshot, By Therapy Type
Market Snapshot, By Mode of Administration
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Epidemiology
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Veterinary Oncology Market - Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the Market
5. Global Veterinary Oncology Market, By Animal Type, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Companion Animal
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Equine
Canine
Feline
Livestock Animal
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
6. Global Veterinary Oncology Market, By Therapy Type, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Chemotherapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Combination Therapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Immunotherapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Targeted Therapy
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
7. Global Veterinary Oncology Market, By Mode of Administration, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Oral
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Intravenous
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
8. Global Veterinary Oncology Market, By Application, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Canine Lymphoma
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Osteosarcoma (OSA)
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Mast Cell Cancer
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Melanoma
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
9. Global Veterinary Oncology Market, By Distribution Channel, 2019 – 2031, (USD Mn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 – 2031
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Government Agencies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Mn)
10. Global Veterinary Oncology Market, By Region, 2019 – 2031, (USD Mn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Region, 2020–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Mn)
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa
11. Competitive Landscape
Company Profiles
Zoetis Inc.*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Elanco
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
VetDC
Morphogenesis, Inc.
Karyopharm Therapeutics, Inc.
Regeneus Ltd.
AdvaVet, Inc.
Rhizen Pharmaceutical SA.
PetCure Oncology
Varian Medical Systems
Accuray Incorporated
One Health
Regeneus Ltd.
12. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
13. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 47 market data tables and 45 figures on "Veterinary Oncology Market” - Global forecast to 2031